Key Highlights

  • Shares rose 0.08% to USD 19.88 on relative Volume of 2.04.
  • Each share converts to USD 20.25 in cash under the Merger agreement.
  • Third-quarter net loss was USD 9.2 million, against USD 1,367.0 million.
  • Closing is expected in the first half of 2027.

Accelerant (NYSE:ARX) shares traded at USD 19.88 on November 20, 2026, up 0.08%, with a relative volume at time of 2.04. The company has given no reason for the activity. On record are a merger agreement with affiliates of Thoma Bravo, signed on August 13, 2026, and a Quarterly Report for the period ended September 30, 2026, filed on November 12.

Accelerant Holdings is a Cayman Islands company based in Grand Cayman. Through its data-driven Accelerant Risk Exchange, it connects selected specialty insurance underwriters, called Members and typically MGAs, with Risk Capital Partners. It provides property and casualty insurance to policyholders through that network, focusing on small-to-medium sized commercial clients mainly in the United States, Europe, Canada and the United Kingdom. It reports three segments: Exchange Services, MGA Operations and Underwriting.

The Merger Agreement

On August 13, 2026 the company agreed to merge with Cherry Tree BidCo and Cherry Tree Merger Sub, affiliates of Thoma Bravo Discover Fund V, L.P. Each Class A and Class B common share converts into the right to receive USD 20.25 in cash, without interest, plus, if applicable, a ticking amount of USD 0.00333 per share for each calendar day elapsed after the start date.

Closing is subject to customary conditions, including Shareholder and regulatory approvals, and is expected in the first half of 2027. The shares will be Delisted from the New York Stock Exchange on completion. In specified circumstances the company must pay Parent a termination fee of USD 136.5 million, and Parent must pay the company USD 295.8 million. Fees contingent on closing are estimated at USD 70 million to USD 85 million, and USD 8.1 million of merger-related professional costs sit in other expenses.

Third-Quarter Results

Total revenues were USD 278.6 million versus USD 267.4 million. Net earned premiums were USD 113.9 million versus USD 82.1 million, direct commission income was USD 90.9 million, and ceding commission income was USD 70.2 million versus USD 92.3 million.

Total expenses were USD 280.2 million versus USD 1,624.9 million, which had included USD 1,379.7 million of profits interest distribution expenses. The loss before income taxes was USD 1.6 million, and the net loss was USD 9.2 million versus USD 1,367.0 million. The loss attributable to common shareholders was USD 12.3 million, or USD 0.06 per share, versus USD 1,439.7 million, or USD 6.99.

Exchange Written Premium was USD 1,329.6 million versus USD 1,042.9 million, and the gross loss ratio was 56.8% versus 50.1%. Adjusted EBITDA, a non-GAAP measure, was USD 71.3 million versus USD 65.5 million, while adjusted net income, also non-GAAP, was USD 38.2 million versus USD 48.6 million.

Nine Months

Total revenues were USD 908.8 million versus USD 664.5 million. Net Income was USD 66.7 million, a turnaround from a net loss of USD 1,346.1 million, and net income attributable to common shareholders was USD 61.2 million, or USD 0.28 per diluted share.

Balance Sheet and Cash Flow

Total Assets were USD 9,456.1 million against USD 8,263.1 million at year end. Cash and cash equivalents were USD 2,019.3 million versus USD 1,604.0 million. Unearned premiums were USD 2,239.2 million and ceded unearned premiums were USD 1,889.5 million. Debt, a senior unsecured Facility due 2029, was USD 119.5 million versus USD 121.3 million.

Total liabilities were USD 8,695.1 million and total Equity was USD 761.0 million versus USD 726.4 million. Operating Cash Flow for nine months was USD 231.0 million versus USD 383.2 million.

What to Watch Next for Accelerant

The company has given no reason for the November 20 volume, and its results were reported earlier. The reported facts are a cash merger at USD 20.25 per share, a small third-quarter net loss and higher Revenue and written premium. Shareholder and regulatory approvals and the first-half 2027 closing window are the points to follow.